87 related articles for article (PubMed ID: 11169931)
1. Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.
Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
Cancer; 2001 Feb; 91(3):490-5. PubMed ID: 11169931
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy.
Ishii H; Okada S; Nose H; Yoshimori M; Aoki K; Okusaka T
Pancreas; 1996 Apr; 12(3):267-71. PubMed ID: 8830333
[TBL] [Abstract][Full Text] [Related]
4. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
Cancer; 1997 Apr; 79(8):1516-20. PubMed ID: 9118032
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure.
Morganti AG; Forni F; Macchia G; Valentini V; Smaniotto D; Trodella L; Balducci M; Cellini N
Strahlenther Onkol; 2003 Feb; 179(2):87-92. PubMed ID: 12590318
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
[TBL] [Abstract][Full Text] [Related]
8. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
Fritz P; Stoll P; Wannenmacher M; Zierhut D
Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
[TBL] [Abstract][Full Text] [Related]
9. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
10. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
Ren H; Wang LH; Wang XZ; Lü JM; Ji W; Zhou ZM; Ou GF; Yin WB
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):143-7. PubMed ID: 19538894
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy.
Okada S; Okazaki N; Nose H; Yoshimori M; Aoki K
Hepatology; 1992 Jul; 16(1):112-7. PubMed ID: 1377657
[TBL] [Abstract][Full Text] [Related]
12. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy.
Kou T; Kanai M; Yamamoto M; Xue P; Mori Y; Kudo Y; Kurita A; Uza N; Kodama Y; Asada M; Kawaguchi M; Masui T; Mizumoto M; Yazumi S; Matsumoto S; Takaori K; Morita S; Muto M; Uemoto S; Chiba T
Int J Clin Oncol; 2016 Feb; 21(1):118-25. PubMed ID: 26123314
[TBL] [Abstract][Full Text] [Related]
13. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
14. Small-field radiotherapy in combination with concomitant chemotherapy for locally advanced pancreatic carcinoma.
Tokuuye K; Sumi M; Kagami Y; Murayama S; Ikeda H; Ikeda M; Okusaka T; Ueno H; Okada S
Radiother Oncol; 2003 Jun; 67(3):327-30. PubMed ID: 12865182
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW;
N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
[TBL] [Abstract][Full Text] [Related]
17. Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.
Okusaka T; Okada S; Tokuuye K; Wakasugi H; Saisho H; Ishikawa O; Matsuno S; Sato T; Sato K;
Cancer; 2001 Apr; 91(7):1384-9. PubMed ID: 11283940
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
19. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
[TBL] [Abstract][Full Text] [Related]
20. [5-FU based chemoradiotherapy for unresectable locally advanced pancreatic cancer].
Niki T; Soejima T; Yoshikawa T; Yamamoto Y; Fujii O; Ohta Y; Tsuda M; Horita K; Tsujino K; Hirohata S; Fujino Y; Nishisaki H
Gan To Kagaku Ryoho; 2009 Jan; 36(1):63-9. PubMed ID: 19151565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
